Surgical robotics, spine implants, digital OR infrastructure, and physician education. Rod invests in medtech because he uses medtech. His perspective is clinical, not financial.
Investing is a secondary activity that follows his clinical identity, not the other way around.
Does the data exist? Is it real or projected?
Will surgeons actually use this in a real OR, under real time pressure?
Does it move the needle for the patient, or just the P&L?
Can it be taught, standardized, and replicated across surgical programs?
Each area reflects something he has lived directly: in the OR, in the lab, or in a courtroom.
"I have used bad tools and good ones. I know what the difference feels like mid-case. That is the only perspective I can offer a founder, and it is the only one I actually trust."
He cannot add useful clinical judgment to products outside his daily practice. These categories fall outside that scope.
Does this make it easier for a physician to do the right thing for a patient, or does it route around that relationship entirely? The answer usually clarifies things quickly.
No response within 3 weeks means the product falls outside the current thesis. He does not respond to decline.
The Seattle Science Foundation streams free surgical case discussions and lectures, plus a free video library on SSFTV. Open to surgeons, residents, and students.